Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glucon, Suzuken in glucose monitoring device deal

This article was originally published in Clinica

Executive Summary

Boulder, Colorado-based Glucon has struck a deal with Japanese pharmaceuticals distributor Suzuken concerning the former's glucose monitoring watch (GMW). Under the agreement, Suzuken, which controls 50% of the Japanese diabetes market through its SKK subsidiary, will gain exclusive marketing rights to GMW in that region and be responsible for taking the product through the Japanese regulatory process. In exchange, Suzuken has made an equity investment in Glucon during a recent round of financing, in which other venture capital firms including Giza Venture Capital, Infinity Venture Capital Fund, Reslo Life Sciences and Ascend Technology Ventures also took part.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel